Bone substitutes as carriers for transforming growth factor-beta(1) (TGF-beta(1))

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedics

Background:

• Hydroxyapatite is a key component of bone and is widely used in bone regeneration.
• Transforming growth factor-beta 1 (TGF-beta(1)) is a potent growth factor that stimulates bone formation.
• Developing effective delivery systems for TGF-beta(1) is crucial for enhancing bone regeneration therapies.

Purpose of the Study:

• To evaluate the suitability of three hydroxyapatite materials (Endobone, Bio-Oss, Algipore) as carriers for TGF-beta(1).
• To investigate the release kinetics of TGF-beta(1) from these hydroxyapatite carriers in different media.

Main Methods:

• Hydroxyapatite materials were loaded with recombinant human TGF-beta(1) (hrTGF-beta(1)).
• Release experiments were conducted by suspending loaded materials in phosphate-buffered saline (PBS) or human serum albumin (HSA).
• hrTGF-beta(1) concentrations were quantified over 28 days using established methods.

Main Results:

• All tested hydroxyapatite materials demonstrated suitability as TGF-beta(1) carriers.
• Release of TGF-beta(1) into HSA exhibited biphasic kinetics for Endobone and Bio-Oss, with an initial rapid release followed by a slower decline.
• Algipore showed a rapid initial release of TGF-beta(1) that decreased significantly by day 2.
• Higher TGF-beta(1) release was observed in HSA compared to PBS for all materials.

Conclusions:

• Endobone, Bio-Oss, and Algipore are suitable carriers for TGF-beta(1).
• The release profile of TGF-beta(1) is dependent on the specific hydroxyapatite material and the release medium.
• These findings support the potential use of these hydroxyapatite-TGF-beta(1) complexes in bone regeneration applications.